66 studies found for:    vaccine adverse reactions | Open Studies
Show Display Options
Rank Status Study
21 Recruiting αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface;   Malignant Peritoneal Mesothelioma;   Peritoneal Carcinomatosis
Interventions: Biological: DC vaccine;   Drug: Celecoxib;   Drug: Interferon Alfa-2b;   Biological: rintatolimod
22 Recruiting Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Conditions: Hepatitis B Infection;   Chronic Infection;   Viremia
Intervention: Drug: TDF treatment
23 Recruiting Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector
Condition: Severe Combined Immunodeficiency
Intervention: Biological: Gene transfer
24 Unknown  Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer
Conditions: Adjuvant Chemotherapy;   Colon Cancer;   Immunity
Interventions: Dietary Supplement: zinc;   Other: Placebo
25 Recruiting Study of the Safety of a Particular Herpes Vaccine in Adults With or Without Herpes Infection
Conditions: Genital Herpes;   Herpes Simplex Virus;   Herpes Simplex Virus Vaccines;   HSV Vaccines;   Herpesvirus Vaccines
Intervention: Biological: HSV529
26 Recruiting A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years
Condition: Meningococcal Vaccine
Interventions: Biological: rLP2086;   Biological: Havrix (HAV);   Biological: Saline
27 Recruiting A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Non-Elderly Adults and Elderly Subjects
Condition: Influenza
Intervention: Biological: AdimFlu-V
28 Recruiting A Study To Investigate A Clostridium Difficile Vaccine In Healthy Adults Aged 50 to 85 Years, Who Will Each Receive 3 Doses Of Vaccine.
Condition: Clostridium Difficile Associated Disease
Interventions: Biological: Clostridium difficile vaccine;   Biological: Placebo
29 Recruiting A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old
Condition: Influenza
Intervention: Biological: AdimFlu-V
30 Unknown  A Phase Ib Trial of MSP 3 LSP in 1-2 Year Old Children in Burkina Faso
Condition: Malaria
Interventions: Biological: MSP 3 Long Synthetic Peptide;   Biological: Hepatitis B vaccine;   Biological: Hepatitis B control vaccince
31 Not yet recruiting Safety Study of Live Shigella Vaccine in Bangladeshi Adults and Children
Condition: Diarrhea
Intervention: Biological: WRSS1
32 Recruiting A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines
Condition: Cholera
Intervention: Biological: Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell
33 Recruiting A Post-marketing Study to Monitor the Safety of a MF59-adjuvanted Influenza Vaccine Administered in Korean Subjects Aged 65 Years or Older
Condition: Influenza
Intervention: Biological: MF59- adjuvanted influenza subunit vaccine
34 Recruiting Study of a Candidate Clostridium Difficile Toxoid Vaccine in Subjects at Risk for C. Difficile Infection
Condition: Clostridium Difficile Infection
Interventions: Biological: C. difficile Toxoid Vaccine;   Biological: Placebo: 0.9% normal saline
35 Not yet recruiting Safety Profile Following Pentabio Vaccination in Indonesian Infants
Condition: Healthy
Intervention:
36 Recruiting Safety and Immunogenicity of Recombinant Pichia Pastoris AMA1-DiCo Candidate Malaria Vaccine With GLA-SE and Alhydrogel ® as Adjuvant in Healthy Malaria Non-Exposed European and Malaria Exposed African Adults
Condition: Safety of Candidate Malaria Vaccine
Interventions: Biological: Group A1 : 50µg AMA1-DiCo + Alhydrogel;   Biological: Group A2 : 50 µg AMA1-DiCo+ GLA-SE;   Biological: Group B2 : Placebo
37 Unknown  Safety and Immunogenicity of Apical Membrane Antigen 1 (PfAMA-1-FVO[25-545])
Condition: Malaria
Interventions: Biological: Malaria vaccine AMA1 (PfAMA-1-FVO[25-545];   Biological: AMA1
38 Recruiting A Study to Assess the Safety and Tolerability of Different Doses of PF-05402536 and PF-06413367 in Healthy Adult Smokers.
Conditions: Smoking;   Vaccines
Interventions: Biological: NIC7-001;   Biological: NIC7-003;   Biological: Saline
39 Recruiting Regulatory Post-Marketing Surveillance Study for TETRAXIM™
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Intervention: Biological: TETRAXIM™: Combined adsorbed diphtheria, tetanus, acellular pertussis and enhanced inactivated polio
40 Recruiting Phase I/II Descending Age Study of P2VP8 Subunit Parenteral Rotavirus Vaccine in Healthy Toddlers and Infants
Condition: Evaluation of a Rotavirus Vaccine
Interventions: Biological: P2VP8 Subunit Vaccine 10mcg;   Biological: P2VP8 Subunit Vaccine 30 mcg;   Biological: P2VP8 Subunit Vaccine 60mcg;   Biological: Placebo;   Biological: Cohort B2 P2VP8 D1;   Biological: Cohort B2 P2VP8 D2

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years